On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)
Samia Mora, Robert J Glynn, S Matthijs Boekholdt, Børge G Nordestgaard, John J P Kastelein, Paul M Ridker
70Citations
(Scopus)
Fingerprint
Dive into the research topics of 'On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)'. Together they form a unique fingerprint.